The ability of telmisartan, an AT1R blocker and a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, to inhibit EC cell proliferation and tumor growth in nude mice adds further evidence to such hypotheses [17]. Here, PPARG is linked to neoplasm.